Sign in
Taking peoplePhase 4

Avian influenza vaccine immunity

Key facts

Who runs it
Finnish Institute For Health And Welfare
Where
Finland1 site in 1 countryChoose a country to see its sites
Status
Recruiting
Phase
Phase 4
People taking part
300 people, planned
Started
26 Jun 2024
Expected to end
31 Dec 2034
Type of study
Interventional
Record updated
21 January 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Age 18 to 65 years
  • Belongs to the target group of the avian influenza vaccine
  • Is planning to receive at least one dose of the avian influenza vaccine
  • Is able to understand the given written and oral information
  • Has given written informed consent
  • Home address in Finland
  • Is able to give samples 3 weeks after each vaccine dose and preferably also participate in the follow-up at 6 and 12 months
  • Pregnant and lactating women can participate in the study

Who cannot take part

  • None

This trial is currently available in Finland.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The main objective of this study is to evaluate the humoral and cell-mediated immune responses induced by the customized avian influenza vaccine, specifically against the H5N1 2.3.4.4b clade.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Avian and seasonal influenza vaccine induced immune responses
Record updated
21 January 2026